相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Contrasting effects of sunitinib within in vivo models of metastasis
Jonathan C. Welti et al.
ANGIOGENESIS (2012)
Differential drug class-specific metastatic effects following treatment with a panel of angiogenesis inhibitors
Alicia S. Chung et al.
JOURNAL OF PATHOLOGY (2012)
Anti-VEGF antibody therapy does not promote metastasis in genetically engineered mouse tumour models
Mallika Singh et al.
JOURNAL OF PATHOLOGY (2012)
ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary
Marianne Pavel et al.
NEUROENDOCRINOLOGY (2012)
ALK1 as an emerging target for antiangiogenic therapy of cancer
Sara I. Cunha et al.
BLOOD (2011)
Pericytes promote endothelial cell survival through induction of autocrine VEGF-A signaling and Bcl-w expression
Marcela Franco et al.
BLOOD (2011)
Targeting Activin Receptor-Like Kinase 1 Inhibits Angiogenesis and Tumorigenesis through a Mechanism of Action Complementary to Anti-VEGF Therapies
Dana D. Hu-Lowe et al.
CANCER RESEARCH (2011)
Lack of Primary Cilia Primes Shear-Induced Endothelial-to-Mesenchymal Transition
Anastasia D. Egorova et al.
CIRCULATION RESEARCH (2011)
TGF-β Receptor Signaling Pathways in Angiogenesis; Emerging Targets for Anti-Angiogenesis Therapy
Laurens A. van Meeteren et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Use of a Mouse Model of Pancreatic Neuroendocrine Tumors to Find Pericyte Biomarkers of Resistance to Anti-angiogenic Therapy
M. Franco et al.
HORMONE AND METABOLIC RESEARCH (2011)
Soluble Endoglin Specifically Binds Bone Morphogenetic Proteins 9 and 10 via Its Orphan Domain, Inhibits Blood Vessel Formation, and Suppresses Tumor Growth
Roselyne Castonguay et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors.
Eric Raymond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Everolimus for Advanced Pancreatic Neuroendocrine Tumors.
James C. Yao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Hereditary haemorrhagic telangiectasia Pathophysiology, diagnosis and treatment
Claire L. Shovlin
BLOOD REVIEWS (2010)
Matrix Metalloproteinase-14 (MT1-MMP)-Mediated Endoglin Shedding Inhibits Tumor Angiogenesis
Lukas J. A. C. Hawinkels et al.
CANCER RESEARCH (2010)
Endothelial progenitor cells give rise to pro-angiogenic smooth muscle-like progeny
Jan-Renier A. J. Moonen et al.
CARDIOVASCULAR RESEARCH (2010)
Pathogenesis of Arteriovenous Malformations in the Absence of Endoglin
Marwa Mahmoud et al.
CIRCULATION RESEARCH (2010)
Dextran Sulfate Sodium Leads to Chronic Colitis and Pathological Angiogenesis in Endoglin Heterozygous Mice
Mirjana Jerkic et al.
INFLAMMATORY BOWEL DISEASES (2010)
Survival Benefit With Proapoptotic Molecular and Pathologic Responses From Dual Targeting of Mammalian Target of Rapamycin and Epidermal Growth Factor Receptor in a Preclinical Model of Pancreatic Neuroendocrine Carcinogenesis
Christopher W. Chiu et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis
Sara I. Cunha et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma
Iris Helfrich et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
ALK1-Fc Inhibits Multiple Mediators of Angiogenesis and Suppresses Tumor Growth
Dianne Mitchell et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Vascular endothelial growth factor B controls endothelial fatty acid uptake
Carolina E. Hagberg et al.
NATURE (2010)
Conversion of vascular endothelial cells into multipotent stem-like cells
Damian Medici et al.
NATURE MEDICINE (2010)
The Role of the TGF-beta Coreceptor Endoglin in Cancer
Eduardo Perez-Gomez et al.
THESCIENTIFICWORLDJOURNAL (2010)
Signaling by members of the TGF-beta family in vascular morphogenesis and disease
Evangelia Pardali et al.
TRENDS IN CELL BIOLOGY (2010)
Endoglin-Targeted Cancer Therapy
Ben K. Seon et al.
Current Drug Delivery (2010)
The emerging role of TGF-beta superfamily coreceptors in cancer
Carmelo Bernabeu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
John M. L. Ebos et al.
CANCER CELL (2009)
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Marta Paez-Ribes et al.
CANCER CELL (2009)
Tumor and Host-Mediated Pathways of Resistance and Disease Progression in Response to Antiangiogenic Therapy
John M. L. Ebos et al.
CLINICAL CANCER RESEARCH (2009)
Emerging role of bone morphogenetic proteins in angiogenesis
Laurent David et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2009)
Metastasis: from dissemination to organ-specific colonization
Don X. Nguyen et al.
NATURE REVIEWS CANCER (2009)
Endoglin in angiogenesis and vascular diseases
Peter ten Dijke et al.
ANGIOGENESIS (2008)
Modes of resistance to anti-angiogenic therapy
Gabriele Bergers et al.
NATURE REVIEWS CANCER (2008)
Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts
Elisabeth M. Zeisberg et al.
CANCER RESEARCH (2007)
Extracellular control of TGFβ signalling in vascular development and disease
Peter ten Dijke et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
PECAM-1 engagement counteracts ICAM-1-induced signaling in brain vascular endothelial cells
Jean-Pierre Couty et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Sorafenib in advanced clear-cell renal-cell carcinoma
Bernard Escudier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Reduced tumor growth and angiogenesis in endoglin-haploinsufficient mice
Annette Duwel et al.
TUMOR BIOLOGY (2007)
Pericytes limit tumor cell metastasis
XJ Xian et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Reduced angiogenic responses in adult endoglin heterozygous mice
M Jerkic et al.
CARDIOVASCULAR RESEARCH (2006)
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
O Casanovas et al.
CANCER CELL (2005)
Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-β receptor complex
FJ Blanco et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
A multitargeted, metronomic, and maximum-tolerated dose chemo-switch regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer
K Pietras et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Prognostic relevance of CD105+microvessel density in HNSCC patient outcome
T Martone et al.
ORAL ONCOLOGY (2005)
Tumor neoangiogenesis by CD31 and CD105 expression evaluation in breast carcinoma tissue microarrays
C Charpin et al.
CLINICAL CANCER RESEARCH (2004)
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
J Yang et al.
CELL (2004)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Endoglin promotes endothelial cell proliferation and TGF-β/ALK1 signal transduction
F Lebrin et al.
EMBO JOURNAL (2004)
Mouse model for hereditary hemorrhagic telangiectasia has a generalized vascular abnormality
E Torsney et al.
CIRCULATION (2003)
Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer
P Wikström et al.
PROSTATE (2002)
Endoglin expression in early development is associated with vasculogenesis and angiogenesis
L Jonker et al.
MECHANISMS OF DEVELOPMENT (2002)
Endoglin, an ancillary TGF beta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development
HM Arthur et al.
DEVELOPMENTAL BIOLOGY (2000)
分享论文
